CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: olmesartan
Accession: CHEBI:48416
browse the term
Definition: A biphenylyltetrazole that has formula C24H26N6O3.
Synonyms: exact_synonym: 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid
related_synonym: 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid; 4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid; Formula=C24H26N6O3; InChI=1S/C24H26N6O3/c1-4-7-19-25-21(24(2,3)33)20(23(31)32)30(19)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-26-28-29-27-22/h5-6,8-13,33H,4,7,14H2,1-3H3,(H,31,32)(H,26,27,28,29); InChIKey=VTRAEEWXHOVJFV-UHFFFAOYSA-N; SMILES=CCCc1nc(c(C(O)=O)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1)C(C)(C)O
alt_id: MESH:C437965
xref: Beilstein:7502669; CAS:144689-24-7; DrugBank:DB00275; LINCS:LSM-5893
xref_mesh: MESH:C097933
xref: Wikipedia:Olmesartan
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions decreases activity
ISO
olmesartan inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] olmesartan results in decreased activity of ABCB11 protein
CTD
PMID:24014644
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcc2
ATP binding cassette subfamily C member 2
affects transport
ISO
ABCC2 protein affects the transport of olmesartan
CTD
PMID:19505989
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Ace2
angiotensin converting enzyme 2
increases expression
EXP
olmesartan results in increased expression of ACE2 mRNA; olmesartan results in increased expression of ACE2 protein
CTD
PMID:19171689 PMID:28656296
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
EXP
olmesartan inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]; olmesartan inhibits the reaction [Fish Oils inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]]
CTD
PMID:24144775
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Agt
angiotensinogen
decreases expression multiple interactions
EXP ISO
olmesartan results in decreased expression of AGT protein modified form [olmesartan co-treated with PD 123319] inhibits the reaction [AGT protein modified form results in increased abundance of Fatty Acids, Nonesterified]; [olmesartan co-treated with PD 123319] inhibits the reaction [AGT protein modified form results in increased secretion of and results in increased abundance of Triglycerides]
CTD
PMID:16003179 PMID:19171689
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Agtr1a
angiotensin II receptor, type 1a
decreases activity
ISO
olmesartan results in decreased activity of AGTR1 protein
CTD
PMID:17208988
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
EXP
[Pravastatin co-treated with olmesartan] results in increased phosphorylation of AKT1 protein
CTD
PMID:17170375
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Alb
albumin
decreases oxidation
ISO
olmesartan results in decreased oxidation of ALB protein
CTD
PMID:17587751
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Bax
BCL2 associated X, apoptosis regulator
decreases expression
ISO
olmesartan results in decreased expression of BAX protein
CTD
PMID:17208988
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Casp3
caspase 3
multiple interactions
ISO
olmesartan results in decreased expression of and results in decreased activity of CASP3 protein
CTD
PMID:17208988
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Crp
C-reactive protein
decreases expression
ISO
olmesartan results in decreased expression of CRP protein
CTD
PMID:18360012
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cyba
cytochrome b-245 alpha chain
decreases expression
EXP
olmesartan results in decreased expression of CYBA protein
CTD
PMID:17170375
NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721
G
Daxx
death-domain associated protein
decreases expression
ISO
olmesartan results in decreased expression of DAXX protein
CTD
PMID:17208988
NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843
G
Dhfr
dihydrofolate reductase
increases expression
EXP
olmesartan results in increased expression of DHFR protein
CTD
PMID:17170375
NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
G
Fas
Fas cell surface death receptor
decreases expression
ISO
olmesartan results in decreased expression of FAS protein
CTD
PMID:17208988
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Il18
interleukin 18
multiple interactions
EXP
olmesartan inhibits the reaction [Aldosterone results in increased expression of IL18 mRNA]
CTD
PMID:18660453
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il6
interleukin 6
decreases expression
ISO
olmesartan results in decreased expression of IL6 protein
CTD
PMID:18360012
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases activity
ISO
olmesartan results in decreased activity of JUN protein
CTD
PMID:17208988
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Map3k7
mitogen activated protein kinase kinase kinase 7
multiple interactions
EXP
Olmesartan inhibits the reaction [Angiotensin II increases phosphorylation of Map3k7 protein in the heart]
RGD
PMID:26706286
RGD:155791673
NCBI chr 5:46,356,973...46,415,597
Ensembl chr 5:46,357,931...46,415,597
G
Mapk1
mitogen activated protein kinase 1
increases expression
ISO
olmesartan results in increased expression of MAPK1 protein modified form
CTD
PMID:17208988
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases expression
ISO
olmesartan results in increased expression of MAPK3 protein modified form
CTD
PMID:17208988
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
decreases expression decreases activity
ISO
olmesartan results in decreased expression of MAPK8 protein modified form olmesartan results in decreased activity of MAPK8 protein
CTD
PMID:17208988
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
decreases expression decreases activity
ISO
olmesartan results in decreased expression of MAPK9 protein modified form olmesartan results in decreased activity of MAPK9 protein
CTD
PMID:17208988
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mas1
MAS1 proto-oncogene, G protein-coupled receptor
increases expression
EXP
olmesartan results in increased expression of MAS1 mRNA; olmesartan results in increased expression of MAS1 protein
CTD
PMID:28656296
NCBI chr 1:47,879,956...47,911,500
Ensembl chr 1:47,880,309...47,911,709
G
Mpo
myeloperoxidase
multiple interactions
EXP
olmesartan inhibits the reaction [Carbon Tetrachloride results in increased activity of MPO protein]; olmesartan inhibits the reaction [Fish Oils inhibits the reaction [Carbon Tetrachloride results in increased activity of MPO protein]]
CTD
PMID:24144775
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Nos3
nitric oxide synthase 3
multiple interactions
EXP
olmesartan promotes the reaction [NOS3 protein binds to NOS3 protein]; olmesartan results in increased activity of and results in increased phosphorylation of NOS3 protein; Pravastatin promotes the reaction [olmesartan results in increased activity of and results in increased phosphorylation of NOS3 protein]
CTD
PMID:17170375
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Nphs1
NPHS1 adhesion molecule, nephrin
increases expression
ISO
Olmesartan increases expression of Nphs1 protein in kidney
RGD
PMID:17229913
RGD:38599164
NCBI chr 1:85,720,812...85,749,079
Ensembl chr 1:85,720,812...85,749,078
G
Pdgfrb
platelet derived growth factor receptor beta
multiple interactions
EXP
olmesartan inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB protein]; olmesartan inhibits the reaction [Fish Oils inhibits the reaction [Carbon Tetrachloride results in increased expression of PDGFRB protein]]
CTD
PMID:24144775
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
EXP
olmesartan inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein]; olmesartan inhibits the reaction [Fish Oils inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein]]
CTD
PMID:24144775
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all